126 related articles for article (PubMed ID: 17611394)
1. XIAP is highly expressed in esophageal cancer and its downregulation by RNAi sensitizes esophageal carcinoma cell lines to chemotherapeutics.
Zhang S; Ding F; Luo A; Chen A; Yu Z; Ren S; Liu Z; Zhang L
Cancer Biol Ther; 2007 Jun; 6(6):973-80. PubMed ID: 17611394
[TBL] [Abstract][Full Text] [Related]
2. The Role of cIAP1 and XIAP in Apoptosis Induced by Tumor Necrosis Factor Alpha in Esophageal Squamous Cell Carcinoma Cells.
Hikami S; Shiozaki A; Kitagawa-Juge M; Ichikawa D; Kosuga T; Konishi H; Komatsu S; Fujiwara H; Okamoto K; Otsuji E
Dig Dis Sci; 2017 Mar; 62(3):652-659. PubMed ID: 28050781
[TBL] [Abstract][Full Text] [Related]
3. Role of XIAP in inhibiting cisplatin-induced caspase activation in non-small cell lung cancer cells: a small molecule Smac mimic sensitizes for chemotherapy-induced apoptosis by enhancing caspase-3 activation.
Checinska A; Hoogeland BS; Rodriguez JA; Giaccone G; Kruyt FA
Exp Cell Res; 2007 Apr; 313(6):1215-24. PubMed ID: 17291493
[TBL] [Abstract][Full Text] [Related]
4. The HSP90 inhibitor 17-N-allylamino-17-demethoxy geldanamycin (17-AAG) synergizes with cisplatin and induces apoptosis in cisplatin-resistant esophageal squamous cell carcinoma cell lines via the Akt/XIAP pathway.
Ui T; Morishima K; Saito S; Sakuma Y; Fujii H; Hosoya Y; Ishikawa S; Aburatani H; Fukayama M; Niki T; Yasuda Y
Oncol Rep; 2014 Feb; 31(2):619-24. PubMed ID: 24317439
[TBL] [Abstract][Full Text] [Related]
5. Down-regulation of XIAP enhances the radiosensitivity of esophageal cancer cells
Wen X; Han XR; Fan SH; Zhang ZF; Chen L; Yi G; Wu DM; Lu J; Zheng YL
Biosci Rep; 2017 Oct; 37(5):. PubMed ID: 28821565
[TBL] [Abstract][Full Text] [Related]
6. Possible prediction of the response of esophageal squamous cell carcinoma to neoadjuvant chemotherapy based on gene expression profiling.
Shen LY; Wang H; Dong B; Yan WP; Lin Y; Shi Q; Chen KN
Oncotarget; 2016 Jan; 7(4):4531-41. PubMed ID: 26673820
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the effect of p65 siRNA and curcumin in promoting apoptosis in esophageal squamous cell carcinoma cells and in nude mice.
Tian F; Zhang C; Tian W; Jiang Y; Zhang X
Oncol Rep; 2012 Jul; 28(1):232-40. PubMed ID: 22552693
[TBL] [Abstract][Full Text] [Related]
8. Nanog siRNA plus Cisplatin may enhance the sensitivity of chemotherapy in esophageal cancer.
Du Y; Shi L; Wang T; Liu Z; Wang Z
J Cancer Res Clin Oncol; 2012 Oct; 138(10):1759-67. PubMed ID: 22714588
[TBL] [Abstract][Full Text] [Related]
9. eIF4E promotes tumorigenesis and modulates chemosensitivity to cisplatin in esophageal squamous cell carcinoma.
Liu T; Li R; Zhao H; Deng J; Long Y; Shuai MT; Li Q; Gu H; Chen YQ; Leng AM
Oncotarget; 2016 Oct; 7(41):66851-66864. PubMed ID: 27588477
[TBL] [Abstract][Full Text] [Related]
10. XIAP gene downregulation by small interfering RNA inhibits proliferation, induces apoptosis, and reverses the cisplatin resistance of ovarian carcinoma.
Ma JJ; Chen BL; Xin XY
Eur J Obstet Gynecol Reprod Biol; 2009 Oct; 146(2):222-6. PubMed ID: 19758744
[TBL] [Abstract][Full Text] [Related]
11. Silencing XIAP suppresses osteosarcoma cell growth, and enhances the sensitivity of osteosarcoma cells to doxorubicin and cisplatin.
Qu Y; Xia P; Zhang S; Pan S; Zhao J
Oncol Rep; 2015 Mar; 33(3):1177-84. PubMed ID: 25572427
[TBL] [Abstract][Full Text] [Related]
12. XIAP Limits Autophagic Degradation of Sox2 and Is A Therapeutic Target in Nasopharyngeal Carcinoma Stem Cells.
Ji J; Yu Y; Li ZL; Chen MY; Deng R; Huang X; Wang GF; Zhang MX; Yang Q; Ravichandran S; Feng GK; Xu XL; Yang CL; Qiu MZ; Jiao L; Yang D; Zhu XF
Theranostics; 2018; 8(6):1494-1510. PubMed ID: 29556337
[No Abstract] [Full Text] [Related]
13. A randomized phase 3 trial comparing paclitaxel plus 5-fluorouracil versus cisplatin plus 5-fluorouracil in Chemoradiotherapy for locally advanced esophageal carcinoma-the ESO-shanghai 1 trial protocol.
Chen Y; Zhu Z; Zhao W; Li L; Ye J; Wu C; Tang H; Lin Q; Li J; Xia Y; Li Y; Zhou J; Zhao K
Radiat Oncol; 2018 Feb; 13(1):33. PubMed ID: 29482649
[TBL] [Abstract][Full Text] [Related]
14. Comparison of cisplatinum/paclitaxel with cisplatinum/5-fluorouracil as first-line therapy for nonsurgical locally advanced esophageal squamous cell carcinoma patients.
Hu G; Wang Z; Wang Y; Zhang Q; Tang N; Guo J; Liu L; Han X
Drug Des Devel Ther; 2016; 10():2129-36. PubMed ID: 27445460
[TBL] [Abstract][Full Text] [Related]
15. Cisplatin induces apoptosis of hepatocellular carcinoma LM3 cells via down-regulation of XIAP.
Shang MJ; Hong DF; Hu ZM; Zhang CW; Wu WD
Eur Rev Med Pharmacol Sci; 2018 Jan; 22(2):382-387. PubMed ID: 29424923
[TBL] [Abstract][Full Text] [Related]
16. NDRG2 suppresses proliferation, migration, invasion and epithelial-mesenchymal transition of esophageal cancer cells through regulating the AKT/XIAP signaling pathway.
Yang CL; Zheng XL; Ye K; Ge H; Sun YN; Lu YF; Fan QX
Int J Biochem Cell Biol; 2018 Jun; 99():43-51. PubMed ID: 29530788
[TBL] [Abstract][Full Text] [Related]
17. Specific down-regulation of XIAP with RNA interference enhances the sensitivity of canine tumor cell-lines to TRAIL and doxorubicin.
Spee B; Jonkers MD; Arends B; Rutteman GR; Rothuizen J; Penning LC
Mol Cancer; 2006 Sep; 5():34. PubMed ID: 16953886
[TBL] [Abstract][Full Text] [Related]
18. Mitotic checkpoint genes, hsMAD2 and BubR1, in oesophageal squamous cancer cells and their association with 5-fluorouracil and cisplatin-based radiochemotherapy.
Tanaka K; Mohri Y; Ohi M; Yokoe T; Koike Y; Morimoto Y; Miki C; Tonouchi H; Kusunoki M
Clin Oncol (R Coll Radiol); 2008 Oct; 20(8):639-46. PubMed ID: 18691855
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of Cks1 increases the radiotherapy resistance of esophageal squamous cell carcinoma.
Wang XC; Tian LL; Tian J; Li D; Wang Y; Wu H; Zheng H; Meng AM
J Radiat Res; 2012; 53(1):72-8. PubMed ID: 22302047
[TBL] [Abstract][Full Text] [Related]
20. Downregulation of XIAP expression induces apoptosis and enhances chemotherapeutic sensitivity in human gastric cancer cells.
Tong QS; Zheng LD; Wang L; Zeng FQ; Chen FM; Dong JH; Lu GC
Cancer Gene Ther; 2005 May; 12(5):509-14. PubMed ID: 15706355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
